Back
Labcorp Holdings Inc. (LH)
Health CareLH · NEW YORK STOCK EXCHANGE, INC. · USD
New to investing? How to read this page →$336.34
+1.06%Weekly undervalued picks
Price · 1 year
Loading live analysis…
Loading analysis…
Intrinsic Investor is for research and education only. Not financial advice.
Key metrics
EPS
$10.46
ROE
11.0%
Gross margin
28.8%
Debt/Equity
0.83x
Revenue growth
5.8%
Labcorp Holdings Inc. — company intelligence
Earnings surprises
Q2 2026$4.99 vs $4.92 est+1.4%
Q1 2026$4.25 vs $4.21 est+1.0%
Q4 2025$4.07 vs $4.06 est+0.3%
Q3 2025$4.18 vs $4.26 est-1.8%
Analyst consensus · 27 analysts
21 Buy6 Hold0 Sell
Updated Aug 21, 2026
Insider activity · 90 days
0 buys7 sellsnet -2,260 shares
Summy Amy B.Sell 924 · Aug 4, 2026
Wilkinson Peter Jother 1,338 · Aug 3, 2026
Wilkinson Peter JSell 82 · Aug 3, 2026
Recent SEC filings
8-K — Material event reportAug 14, 2026
4 — Insider transaction reportAug 12, 2026
4 — Insider transaction reportAug 6, 2026
Latest news
Labcorp CEO Adam Schechter Sells 4,669 Shares for $1.5 Million — Yahoo · 1w ago
Is Labcorp Holdings (LH) Fully Priced Following Oncology Approvals And Raised Outlook? — Yahoo · 1w ago
Did Stronger Guidance, Buybacks and New Oncology Tests Just Shift Labcorp Holdings' (LH) Investment Narrative? — Yahoo · 2w ago
AI Valuation Narrative
Generates a short bull / bear / catalyst summary from the analytics we already computed. No target prices. Research tool, not investment advice.
Explore more
Peers & similar stocks
Quick links to related tickers for research.
Weekly undervalued picks
Get 3 new value ideas and the fair-value math behind them every week. One email, unsubscribe anytime.
Free. No spam. We only email once per week.
Data is provided "as-is" and may be delayed or incomplete. Intrinsic Investor is for education only and is not investment advice.